Search and Browse
Download
Enter Data
BDBM3603 4-N-(3-bromophenyl)-6-N-methylpyrido[3,4-d]pyrimidine-4,6-diamine::4-[(3-bromophenyl)amino]-6-(methylamino)pyrido[3,4-d]pyrimidine::CHEMBL53753::PD158780
SMILES: CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1
InChI Key: InChIKey=KFHMLBXBRCITHF-UHFFFAOYSA-N
Data: 5 IC50
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epidermal growth factor receptor (Human) | BDBM3603![]() (4-N-(3-bromophenyl)-6-N-methylpyrido[3,4-d]pyrimid...) | GoogleScholar | UniChem | n/a | n/a | 0.00800 | n/a | n/a | n/a | n/a | 7.4 | 22 | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Epidermal growth factor receptor (Human) | BDBM3603![]() (4-N-(3-bromophenyl)-6-N-methylpyrido[3,4-d]pyrimid...) | GoogleScholar | UniChem | n/a | n/a | 0.00800 | n/a | n/a | n/a | n/a | 7.4 | 22 | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Epidermal growth factor receptor (Human) | BDBM3603![]() (4-N-(3-bromophenyl)-6-N-methylpyrido[3,4-d]pyrimid...) | GoogleScholar | UniChem | n/a | n/a | 0.00800 | n/a | n/a | n/a | n/a | 7.4 | 22 | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Activated CDC42 kinase 1 (Human) | BDBM3603![]() (4-N-(3-bromophenyl)-6-N-methylpyrido[3,4-d]pyrimid...) | GoogleScholar | UniChem | n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| MAP kinase-interacting serine/threonine-protein kinase 1 (Human) | BDBM3603![]() (4-N-(3-bromophenyl)-6-N-methylpyrido[3,4-d]pyrimid...) | GoogleScholar | UniChem | n/a | n/a | 1.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||